Navigation Links
Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
Date:4/23/2012

SANTA CLARA, Calif., April 23, 2012 /PRNewswire/ -- Ahram Biosystems, Inc., a leading innovator of new life science tools, today announced the launch of Palm PCR F1-12, the economy model of its innovative portable PCR system. The F1-12 system is a cost-effective, high-performance portable PCR system, delivering PCR amplification with high speed and sensitivity in a fully portable format.

The Palm PCR F1-12 system provides three "Standard Fast" speed levels delivering 30-cycle PCR amplification within 30 minutes down to 24 minutes. The amplification sensitivity reaches to near single-copy level below 10 copies. The dynamic range of the PCR amplification is up to 1 kbp. Like other Palm PCR series, it is battery-powered (more than 4 hours of continuous operation on a single charge) and represents high temperature uniformity (less than +/- 0.1 degrees C) and a small footprint and light weight (71 mm x 121 mm x 47 mm or 2.8" x 4.76" x 1.85", 350 g).

The high speed and high sensitivity of the F1-12 system and its affordable price make it ideal for a wide range of downstream applications that require fast and sensitive nucleic acid amplification. Examples include POCT (point-of-care testing), food quality assurance, forensics, educational uses and many other applications of genetic identification purposes. The battery-powered, full portability makes the F1-12 system particularly invaluable where in-field or on-site PCR amplification is crucial. The Palm PCR F1-12 system enables users to perform highly sensitive and accurate PCR amplification in a fully portable format while saving both money and time.

The Palm PCR F1-12 system comes at an affordable price of mid US$3k, in a complete set that includes the main device, a rechargeable battery and other accessories. The F1-12 system is available for order from Ahram Biosystems (www.ahrambio.com) or its global distributors.

About Ahram Biosystems:

Ahram Biosystems, Inc. is a leading innovator of new life science tools, taking the initiative to bring portable innovation to the biotechnology market. The company provides the innovative portable PCR system, Palm PCR(TM), designed to perform polymerase chain reactions for both indoor and outdoor applications. The company has its headquarters in Seoul, Korea and a subsidiary in Santa Clara, California. For more information, visit www.ahrambio.com or contact info@ahrambio.com.


'/>"/>
SOURCE Ahram Biosystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PEG-Liposome siRNA In Vivo Transfection Kit From Altogen Biosystems
2. Glycosan BioSystems Seeks CE Mark in the European Union for HyStem-Rx, a Unique, Implantable Scaffold for Tissue Engineering
3. New Online Tutorials for NCBI resources BioSystems and DCODE
4. Microbix Biosystems Re-files Annual Results With OSC
5. Microbix Biosystems Provides a Corporate Update
6. Celtic Pharma Holdings Announces Investment in Novacta Biosystems Limited
7. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
8. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
9. Prosolia and Indigo BioSystems Come Together to Create FireFly(TM) Data Conversion Software for Mass Spectrometers
10. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
11. Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... BellBrook Labs is formalizing a significant expansion ... biochemical analyses critical for Lead Discovery. The company’s Lead Discovery Services will ... inhibitor potency and selectivity, mechanism of action, and inhibitor residence times on drug ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life Sciences ... line of oncolytic vaccinia viruses for virotherapy research. ... part of Genelux,s proprietary, vaccinia virus-based technology platform ... to enter into a partnership with Genelux to ... vaccinia viruses for use in research," said Dr. ...
(Date:2/23/2017)... ... , ... The Greater Gift Initiative, Inc , (GGI) a Winston-Salem, NC ... GGI's mission is to advance global health and highlight the greater good of clinical ... each clinical trial volunteer. The vision of GGI is to serve as a philanthropic ...
(Date:2/22/2017)... 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet ... innovative biopharmaceutical products for companion animals, will host a live ... ET to discuss financial results from the fourth quarter and ... participants and investors may access the audio webcast ... ...
Breaking Biology Technology:
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
Breaking Biology News(10 mins):